Table 2 Postoperative pain management and adverse events
Study Group (n = 31) | Control Group (n = 32) | Median difference (95% CI) | P value | |
|---|---|---|---|---|
Morphine consumption at 0–24 h (mg) | 5 (2–9) | 8.5 (5–12.8) | -3 (− 6 - − 1) | 0.013 |
Morphine consumption at 24–48 h (mg) | 1 (0–1) | 0 (0–2) | 0 (0–0) | 0.913 |
NRS at 1 h | 3 (2–4) | 4 (3–5) | -1 (− 2–0) | 0.007 |
NRS at 2 h | 3 (2–4) | 3.5 (3–5) | -1 (− 2–0) | 0.010 |
NRS at 6 h | 3 (2–3) | 3 (2.3–4) | -1 (− 1–0) | 0.028 |
NRS at 24 h | 2 (1–3) | 2 (1.5–3) | 0 (− 1–0) | 0.355 |
NRS at 48 h | 1 (1–2) | 1 (1–2.4) | 0 (− 1–0) | 0.283 |
Nausea 0–48 h (n/%) | 8 (25.8%) | 16 (50.0%) | 0.048 | |
Vomiting 0–48 h (n/%) | 7 (21.9%) | 7 (21.9%) | > 0.999 | |
Rescue antiemetics 0–48 h (n/%) | 8 (25.0%) | 6 (18.8%) | 0.545 |